SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study
Clinical trial NCT00511797 · COMPLETED
Trial details
- NCT number
- NCT00511797
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2009-01-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.